tiprankstipranks
Yunji (YJ)
NASDAQ:YJ
US Market

Yunji (YJ) AI Stock Analysis

Compare
155 Followers

Top Page

YJ

Yunji

(NASDAQ:YJ)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
$2.00
▲(55.04% Upside)
Action:UpgradedDate:01/29/26
The score is primarily weighed down by weak financial performance (sharp revenue contraction, persistent losses, and negative operating/free cash flow). Technicals provide only modest near-term support, while valuation remains unattractive/unclear due to negative earnings and no dividend yield data.
Positive Factors
Product Launch Success
Successful product launches like Youjiang Organic Milk indicate Yunji's ability to innovate and capture consumer interest, supporting long-term brand growth.
Negative Factors
Revenue Decline
A significant revenue decline indicates challenges in maintaining sales momentum, which can impact Yunji's ability to sustain growth and profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Product Launch Success
Successful product launches like Youjiang Organic Milk indicate Yunji's ability to innovate and capture consumer interest, supporting long-term brand growth.
Read all positive factors

Yunji (YJ) vs. SPDR S&P 500 ETF (SPY)

Yunji Business Overview & Revenue Model

Company Description
Yunji Inc. operates a social e-commerce platform in the People's Republic of China. It offers a range of product categories that cater various daily needs of users and their households, including beauty and personal care, household goods, cloths, ...
How the Company Makes Money
Yunji generates revenue primarily through its membership model, where users pay a fee to gain access to exclusive deals and discounts on products. The company also earns money through commissions on sales made through its platform, partnering with...

Yunji Earnings Call Summary

Earnings Call Date:Aug 21, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Mar 27, 2026
Earnings Call Sentiment Neutral
While Yunji has achieved notable successes in product launches and brand expansion, the company faced significant financial challenges, including a decline in revenue and increased net loss. The strategic initiatives show promise but are juxtaposed against a backdrop of financial difficulties.
Positive Updates
Successful Launch of Youjiang Organic Milk
Youjiang Organic Milk achieved RMB 5 million in sales at launch, establishing Yunji's health-focused brand awareness among consumers.
Negative Updates
Revenue Decline
Total revenue decreased to RMB 158.3 million from RMB 233.8 million a year ago, mainly due to softer consumer confidence and strategic product selection refinement.
Read all updates
Q2-2025 Updates
Negative
Successful Launch of Youjiang Organic Milk
Youjiang Organic Milk achieved RMB 5 million in sales at launch, establishing Yunji's health-focused brand awareness among consumers.
Read all positive updates
Company Guidance
During Yunji's First Half 2025 Earnings Conference Call, CEO Shanglue Xiao emphasized the company's commitment to an organic health strategy amidst challenging market conditions and declining consumer confidence, with the goal of establishing Yunji's future growth prospects. The flagship product, Youjiang Organic Milk, launched with RMB 5 million in sales, while other successful products included slimming coffee with over RMB 10 million, probiotics bolus nearing RMB 7 million, and freeze-dried sea buckthorn powder exceeding RMB 5 million in sales. The beauty brand SUYE also performed well, with the PRO-XLANE FIRMING Series generating over RMB 10 million. Financial highlights included a total revenue of RMB 158.3 million, down from RMB 233.8 million the previous year, with a gross margin holding steady at 47.3%. Operating expenses rose to RMB 179.4 million, leading to a net loss of RMB 100.7 million, compared to RMB 8 million a year ago. Despite these challenges, the company maintained a cash position of RMB 217.1 million, focusing on optimizing cost structures and improving profitability.

Yunji Financial Statement Overview

Summary
Weak fundamentals: steep multi-year revenue decline, sustained negative EBIT/net income, and consistently negative operating/free cash flow. A relatively strong equity ratio and low leverage provide some balance-sheet stability, but ongoing losses and cash burn dominate the risk profile.
Income Statement
33
Negative
Balance Sheet
45
Neutral
Cash Flow
28
Negative
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue779.75M417.65M640.21M1.15B2.16B5.53B
Gross Profit356.02M206.34M307.44M502.54M811.98M1.59B
EBITDA-73.60M-103.53M-141.07M-93.59M18.65M-65.39M
Net Income-130.60M-123.11M-165.13M-131.34M131.97M-147.86M
Balance Sheet
Total Assets1.67B1.35B1.55B1.89B2.35B2.55B
Cash, Cash Equivalents and Short-Term Investments528.93M219.37M524.74M626.64M947.26M1.20B
Total Debt18.56M11.65M14.50M1.31M8.69M15.30M
Total Liabilities406.81M274.41M362.69M536.51M871.46M1.24B
Stockholders Equity1.27B1.08B1.19B1.36B1.48B1.31B
Cash Flow
Free Cash Flow0.00-318.62M-200.67M-309.08M-112.97M-345.92M
Operating Cash Flow0.00-126.08M-188.26M-216.82M-25.99M-261.51M
Investing Cash Flow0.00-166.33M294.04M92.56M-513.79M551.01M
Financing Cash Flow0.00-13.32M-25.33M-94.56M-463.00K-13.88M

Yunji Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1.29
Price Trends
50DMA
1.52
Positive
100DMA
1.53
Positive
200DMA
1.69
Positive
Market Momentum
MACD
0.10
Negative
RSI
57.98
Neutral
STOCH
92.09
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For YJ, the sentiment is Positive. The current price of 1.29 is below the 20-day moving average (MA) of 1.69, below the 50-day MA of 1.52, and below the 200-day MA of 1.69, indicating a bullish trend. The MACD of 0.10 indicates Negative momentum. The RSI at 57.98 is Neutral, neither overbought nor oversold. The STOCH value of 92.09 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for YJ.

Yunji Risk Analysis

Yunji disclosed 93 risk factors in its most recent earnings report. Yunji reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Yunji Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
54
Neutral
$5.42M-0.85-16.89%31.24%
49
Neutral
$18.47M-9.51%-12.53%-3.24%
45
Neutral
$129.37M-3.89-5.35%6.20%9.12%
44
Neutral
$9.16M-35.95%26.08%
$2.12M-11.9712.11%570.49%
40
Underperform
$3.59M-0.27-373.22%-39.99%-26.44%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
YJ
Yunji
1.86
-0.01
-0.53%
BZUN
Baozun
2.13
-0.82
-27.80%
MOGU
Mogu
2.40
0.13
5.49%
WNW
Meiwu Technology Company Limited
0.13
-2.79
-95.55%
JWEL
Jowell Global
2.50
0.34
15.56%
WBUY
Webuy Global
0.96
0.92
2300.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 29, 2026